Ranking sixth in the United States for federal funding ($357 million), University of Pittsburgh researchers provide both expert analysis/evaluation of biomedical technologies and an outstanding beta site for new therapies. The University is aggressively and strategically exploring opportunities for technology transfer through its Office of Technology Management.